John Peter Gutfreund serves as Executive at Oncocyte Corp, where they oversee executive responsibilities. Since joining the company, John Peter Gutfreund has executed 6 insider transactions totaling $48.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 30, 2023 involved transacting 3,085,047 shares valued at $0.
John Peter Gutfreund currently holds 715,000 shares of Oncocyte Corp (OCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Peter Gutfreund has been a net buyer of OCX stock. They have purchased $48.0K and sold $0 worth of shares.
John Peter Gutfreund's most recent insider trade was on Jun 30, 2023, when they sold 3,085,047 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.35 |
| Discretionary |
| Apr 3, 2023 | OCX | $350.0K | Award | 1,000,000 | $0.35 | Discretionary |
| Dec 23, 2022 | OCX | $24.8K | Purchase | 75,000 | $0.33 | Discretionary |
| Aug 15, 2022 | OCX | $23.3K | Purchase | 25,000 | $0.93 | Discretionary |
| Aug 15, 2022 | OCX | $0 | Award | 10,000 | $N/A | Discretionary |